about
Sex ratio of the mutation frequencies in haemophilia A: coagulation assays and RFLP analysisThe history of blood transfusion.Mutation rates in humans. I. Overall and sex-specific rates obtained from a population study of hemophilia B.von Willebrand's disease: a report from a meeting in the Åland islandsDescriptive epidemiology of hemophilia and other coagulation disorders in mansoura, egypt: retrospective analysis.The pattern of factor IX germ-line mutation in Asians is similar to that of CaucasiansPhysical condition, longevity, and social performance of Dutch haemophiliacs, 1972-85.Treating haemophilia A with recombinant blood factors: a comparison.Shortened Lifespan and Lethal Hemorrhage in a Hemophilia A Mouse ModelThe Hypertension of Hemophilia Is Not Explained by the Usual Cardiovascular Risk Factors: Results of a Cohort Study.The history and evolution of the clinical effectiveness of haemophilia type a treatment: a systematic review.Prevention and treatment of atherosclerosis in haemophilia - how to balance risk of bleeding with risk of ischaemic events.Surgery and survival in birth cohorts with severe haemophilia and differences in access to replacement therapy: The Malmö experience.Life experience of the adult and ageing patient with haemophilia. Practical aspects for psychological support.Mutations causing hemophilia B: direct estimate of the underlying rates of spontaneous germ-line transitions, transversions, and deletions in a human gene.Mortality, health care utilization and associated diagnoses in hospitalized patients with haemophilia in the United States: first reported nationwide estimates.Prenatal diagnosis of haemophilia in Sweden now more commonly used for psychological preparation than termination of pregnancy.US Hemophilia Treatment Center population trends 1990-2010: patient diagnoses, demographics, health services utilization.Increased cancer risk in patients with haemophilia A: a nationwide population-based 14-year study in Taiwan.A study of reported factor IX use around the world.Percutaneous coronary intervention in left main coronary artery disease in a patient with hemophilia B.Inhibitor screening in non-severe haemophilia patients; a major challenge.Comparing thrombin generation in patients with hemophilia A and patients on vitamin K antagonists.Factor IX replacement to cover total knee replacement surgery in haemophilia B: a single-centre experience, 2000-2010.Massive bleeding from a gastric erosion after transcatheter arterial chemoembolization for hepatocellular carcinoma in a patient with mild haemophilia A.Reduced cardiovascular mortality in hemophilia despite normal atherosclerotic load.Safety and complications of interventional radiology for hepatocellular carcinoma in patients with haemophilia and cirrhosis.Classic hemophilia in elderly patients.Incidence, mortality rates and causes of deaths in haemophilia patients in Sweden.Twenty-one years of haemophilia.Successful use of protease inhibitors in HIV-infected haemophilia patients.Factors predictive of death among HIV-uninfected persons with haemophilia and other congenital coagulation disorders.Vedolizumab Treatment for Ulcerative Colitis in an Elderly Multimorbid Patient with Hemophilia A.Inhibition of Tissue Factor Pathway Inhibitor (TFPI) as a Treatment for Haemophilia: Rationale with Focus on Concizumab.
P2860
Q33597606-87580379-F6F5-4B4A-9201-381B7DAB6CC5Q33923279-E9609573-ED76-4E62-B803-4D8423FC9B47Q34146295-14787F98-A133-4BBE-AF21-CD434284CA29Q34223268-8DD02C16-42F1-40C6-8562-A5939A616012Q34549367-A351BEB9-AB99-49C6-A945-E560008329AFQ35198045-54B282DE-9D08-424D-BAF9-67FB5E678B6AQ35707673-B5E197FD-D6CA-489E-942F-A9FC6C3B9345Q35779195-06A82AB2-528F-4911-9769-381F00F40619Q36868829-F192BABF-28EE-4E32-A4CF-CF5F237A1367Q37443624-B58EF142-A74E-44EF-A65A-C2756616B3BFQ37578173-2659C538-0C9D-4310-B48A-91723E000EE2Q38308207-7525396D-A134-4954-BDE8-426E62D95986Q38652396-155F19E7-ADE7-4988-8F56-55103EFB29F7Q39181504-0E0C65E1-186C-48F8-B2C4-401CB109F124Q40584423-7964879B-1136-4199-8242-BCBAECD622B6Q43433675-CF55B38E-92E3-4105-A473-F1DDA1A25C28Q43482130-0F2061B5-02DC-4AE9-858A-11902592BA4EQ43662496-C5B72C8C-13FE-4C0D-B815-96BBA5A93949Q43939427-6798A5E9-9A48-47E3-9ADB-A03E308492F5Q44859791-3A75274A-63BD-4F1E-AD31-7B6E07B8CD57Q45857237-292FE77F-874C-48FC-A0DC-CD26D5A19547Q45864597-C10BF0B6-55A3-4EB1-819E-60637F7D4C90Q45865646-68F7C4A8-1929-4E0E-B08C-55A6B2E1A1E2Q45869833-510DCC68-66C3-4E34-8810-A66BAD867136Q45873304-54BA3219-547D-4B3A-861A-447D8F3EFBA6Q45874280-3DD6E6CB-A89F-4243-9130-47455E90A5F6Q45876270-ACE94146-CFA0-4357-BEAB-4940CA0A4785Q45880349-4210E659-EB04-4EBF-9BF7-68EC73615D65Q45884712-74546953-0257-4A3D-8B02-5DAE2A707BD8Q45886252-E83259A3-C034-46DB-B225-79A9A5E4F178Q45887988-8A5F6BFF-0D11-487C-81D9-063557E54D16Q45888823-57087D08-DA6D-42D3-9A2B-68515A65F022Q52614638-A07991AC-F8C2-4056-9621-42D12E8CB0BFQ55346403-DCB55499-B667-4571-A767-C49554ABDF37
P2860
description
1985 nî lūn-bûn
@nan
1985年の論文
@ja
1985年学术文章
@wuu
1985年学术文章
@zh
1985年学术文章
@zh-cn
1985年学术文章
@zh-hans
1985年学术文章
@zh-my
1985年学术文章
@zh-sg
1985年學術文章
@yue
1985年學術文章
@zh-hant
name
Life expectancy of Swedish haemophiliacs, 1831-1980.
@en
Life expectancy of Swedish haemophiliacs, 1831-1980.
@nl
type
label
Life expectancy of Swedish haemophiliacs, 1831-1980.
@en
Life expectancy of Swedish haemophiliacs, 1831-1980.
@nl
prefLabel
Life expectancy of Swedish haemophiliacs, 1831-1980.
@en
Life expectancy of Swedish haemophiliacs, 1831-1980.
@nl
P1476
Life expectancy of Swedish haemophiliacs, 1831-1980.
@en
P2093
Larsson SA
P304
P356
10.1111/J.1365-2141.1985.TB07353.X
P407
P577
1985-04-01T00:00:00Z